Patients with MS. Multiple sclerosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria included no smoking, no regular exercise at least two years of history
Exclusion criteria
Exclusion criteria: Muscle injuries, inability to perform exercise severe recurrence of the disease participation in a training program other than the training protocol of research pregnancy recurrence of MS in the last 12 weeks change in MS medication or steroid treatment in 12 weeks Past and period of practice non-cooperation until the end of the research process severe recurrence of the disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physical function based on 6 minutes walking time. Timepoint: Periods of this study before the intervention and 2 days after the intervention. Method of measurement: Measurement of physical function (cardiorespiratory endurance) by 6-minute walking test.;Investigation of inflammatory status. Timepoint: Measurement of serum cysteine 1 and chemokine 20. Method of measurement: Before intervention and 2 days after intervention.;Check serum vitamin D status. Timepoint: Before intervention and 2 days after intervention. Method of measurement: Examination of blood serum vitamin D by the kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Assess stress and anxiety. Timepoint: Before the intervention and 2 days after the intervention. Method of measurement: By means of the DASS-21 Stress-Anxiety Questionnaire.;Evaluation of resilience. Timepoint: Before the intervention and 2 days after the intervention. Method of measurement: By Connor-Davidson Resilience Questionnaire.;Evaluation of sleep quality. Timepoint: Before the intervention and 2 days after the intervention. Method of measurement: By Sleep Quality Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
the Hakim Sabzevari University